Pharos IBT

Drug Discovery

This company develops an artificial intelligence platform for automated molecular synthesis and drug discovery to assist pharmaceutical researchers in creating novel therapeutics.

Vibe Bio

This company develops artificial intelligence software for biopharmaceutical firms to evaluate drug assets and also invests in therapeutics for rare diseases.

Recursion Pharmaceuticals

This company develops artificial intelligence platforms to discover and develop medicines for pharmaceutical partners and patients with rare diseases and cancer.

Xaira

The company develops artificial intelligence platforms to design and develop antibody-based medicines for patients with various diseases.

UbiquiTx

This company develops a programmable protein modulation platform using artificial intelligence to create targeted therapies for pharmaceutical businesses and patients with complex diseases.

Iambic Therapeutics

This company develops artificial intelligence platforms for drug discovery and clinical-stage therapeutics for biopharmaceutical partners and healthcare sectors.

Technology-enabled pharmaceutical company

This company develops small molecule drug candidates using artificial intelligence for the pharmaceutical and biotechnology industries.

Gain Therapeutics

This biotechnology company develops allosteric small molecule therapies for patients with neurodegenerative diseases and rare genetic disorders using an artificial intelligence drug discovery platform.